Table 1.
Characteristics of 85 men with COPD at entry.
| Characteristic | Mean (SD) | Range | |
|---|---|---|---|
| Age, yrs | 72.7 (8.4) | 46.6–89.9 | |
| Education, yrs | 12.9 (2.1) | 8–20 | |
| BMI, kg/m2 | 29.8 (5.6) | 19.6–51.4 | |
| Pack years | 64.0 (41.0) | 10–212 | |
| Post bronchodilator %-predicted FEV1 | 68.1 (20.6) | 16.7–122.3 | |
| Post bronchodilator %-predicted FVC | 88.5 (18.5) | 53.1–143.3 | |
| COPD Classification | N (%) | ||
| GOLD severity | 1 | 18 (21.2%) | |
| 2 | 47 (55.3%) | ||
| 3 | 6 (7.1%) | ||
| 4 | 5 (5.9%) | ||
| Normal spirometrya | 6 (7.0%) | ||
| Normal FEV1/FVC, reduced FEV1a | 3 (3.5%) | ||
| Race | White | 76 (89.4)% | |
| Non-Whiteb | 9 (10.6%) | ||
| Asthma | 18 (21.2%) | ||
| Diabetes | 21 (24.7%) | ||
| Heart disease | 44 (51.8%) | ||
| Obesity (BMI ≥30) | 39 (45.8%) | ||
| Statin use | 66 (77.6%) | ||
| Inhaled steroid use | 65 (76.5%) |
a
Emphysema on clinical CT report.
b
Includes 8 Black/African American participants. Predicted values for FVC and FEV1 based on NHANES.